In an Alzheimer’s disease model, spironolactone prevented cognitive decline, thought to be meditated via increasing BDNF protein levels53 and schizophrenic patients have been shown in a meta-analysis to have reduced plasma levels of this neurothrophin54. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.